Surmodics INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

GAMCO Investors and affiliated entities have divested their entire beneficial ownership in Surmodics Inc. following the completion of its acquisition by an affiliate of GTCR LLC.
A group of investment entities led by Mario Gabelli has disclosed a 5.02% beneficial ownership stake in Surmodics Inc., acquired for investment purposes with a focus on enhancing shareholder value.